Behind the ad by the national government that it will begin to vaccinate boys from three to twelve years with the Sinopharm, the former Minister of Health, Adolfo Rubinstein, opined: “I think this is an issue that should be approached with prudence and looking at the whole picture,” so he demanded that it is important to analyze some issues. For this reason, he spread his reflections.

Using his personal Twitter account, Adolfo Rubinstein, a family doctor, began by listing his medical reflections on the vaccine that would be applied to children: “We are still in a pandemic and we still don’t know what will happen in our country with the Delta variant ”. However, he showed that the current health situation is much “calmer than four months ago.”

Even so, he affirmed that, although it is not predominant in Argentina, the Delta variant is much more transmissible than the others. “Herd immunity for the virus to stop circulating is achieved, not with 70% of the immunized population as before, but with> 90%,” he explained. And, from his knowledge and work as a doctor, he showed that, to prevent the circulation of the most transmissible variants, it is necessary that almost the entire population, including children, be protected.

However, he explained that the preliminary results of the use of the vaccine in young children are “auspicious”, that is, beneficial, the results of the clinical trials that conclude this response have not yet been published. Therefore, Rubinstein stated: “This is a population for which any vaccine must be approved with greater evidence than for another age group.”

Finally, the Argentine Society of Pediatrics provided a statement explaining that it must be “very cautious with the indications to children and demand more evidence”, faced with this “dilemma between the need to apply vaccination and the special care that we must have with children, “added the former Minister of Health. And then he sentenced: “It is not a thing that these decisions, instead of being thought with epidemiological criteria, are driven by electoral criteria and because of the Sinopharm stock.”

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more